Babak, O. Y., and K. A. Lapshyna. “The Fibroblasts Growth Factor 21 Study in Patients With Non-Alcoholic Fatty Liver Disease and Hypertension Comorbidities”. Zaporozhye мedical Journal, vol. 22, no. 2, Apr. 2020, doi:10.14739/2310-1210.2020.2.200572.